Myasthenia Gravis Pathogenesis and Current Concepts in Management
- 1 August 1983
- journal article
- Published by Springer Nature in Drugs
- Vol. 26 (2) , 174-184
- https://doi.org/10.2165/00003495-198326020-00004
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.BMJ, 1983
- A Prospective Study of Thymectomy and Serum Acetylcholine Receptor Antibodies in Myasthenia GravisAnnals of Surgery, 1982
- EFFECT OF IMMUNOSUPPRESSIVE DRUGS (AZATHIOPRINE)Annals of the New York Academy of Sciences, 1981
- THE EFFECT OF ANTI‐THYMOCYTE ANTISERUM IN PROGRESSIVE MY ASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1981
- CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVISBrain, 1980
- Controversies about the treatment of myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Cancer and Teratogenesis: Infrequent Occurrence after Medical Use of Immunosuppressive Drugs*Australian and New Zealand Journal of Medicine, 1977
- The Value of Thymectomy in Myasthenia GravisAnnals of Surgery, 1976
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine ReceptorsScience, 1974
- Tumours of the thyroid gland in relation to some general concepts of neoplasiaJournal of the Faculty of Radiologists, 1959